Triple therapy with ELX/TEZ/IVA is superior to dual therapy with TEZ/IVA in the treatment of CF-CRS, as significantly reduced sinonasal complaints, nasal endoscopy and CT scores were observed after triple therapy, whereas this was not the case for dual therapy.
Keyphrases
- cystic fibrosis
- chronic rhinosinusitis
- end stage renal disease
- newly diagnosed
- computed tomography
- pseudomonas aeruginosa
- stem cells
- chronic kidney disease
- magnetic resonance imaging
- mesenchymal stem cells
- prognostic factors
- magnetic resonance
- bone marrow
- cell therapy
- chronic obstructive pulmonary disease
- contrast enhanced
- combination therapy
- dual energy